// April 17, 2023
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply of Quality Medicines
In the U.S. and around the world, quality standards developed by the U.S.
In the U.S. and around the world, quality standards developed by the U.S.
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
By Luc Besançon, Pharm.D. | Chief Executive Officer, International
The Root Causes of Substandard Medicines in Lower and Middle Income Countries (LMICs)